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Susceptibility Locus on Chromosome 1q23-25
for a Schizophrenia Subtype Resembling Deficit
Schizophrenia Identified by Latent Class Analysis
Elizabeth G. Holliday, PhD; Duncan E. McLean, MA; Dale R. Nyholt, PhD; Bryan J. Mowry, MD, FRANZCP
Context: Identifying susceptibility genes for schizo-
phrenia may be complicated by phenotypic heteroge-
neity, with some evidence suggesting that phenotypic
heterogeneity reflects genetic heterogeneity.
Objective: To evaluate the heritability and conduct ge-
netic linkage analyses of empirically derived, clinically
homogeneous schizophrenia subtypes.
Design: Latent class and linkage analysis.
Setting: Taiwanese field research centers.
Participants: The latent class analysis included 1236
Han Chinese individuals with DSM-IV schizophrenia.
These individuals were members of a large affected-
sibling-pair sample of schizophrenia (606 ascertained
families), original linkage analyses of which detected a
maximum logarithm of odds (LOD) of 1.8 (z=2.88) on
chromosome 10q22.3.
MainOutcomeMeasures: Multipoint exponential LOD
scores by latent class assignment and parametric hetero-
geneity LOD scores.
Results: Latent class analyses identified 4 classes, with
2 demonstrating familial aggregation. The first (LC2) de-
scribed a group with severe negative symptoms, disor-
ganization, and pronounced functional impairment, re-
sembling “deficit schizophrenia.” The second (LC3)
described a group with minimal functional impairment,
mild or absent negative symptoms, and low disorgani-
zation. Using the negative/deficit subtype, we detected
genome-wide significant linkage to 1q23-25 (LOD=3.78,
empiric genome-wide P=.01). This region was not de-
tected using theDSM-IV schizophrenia diagnosis, but has
been strongly implicated in schizophrenia pathogenesis
by previous linkage and association studies.Variants in
the 1q region may specifically increase risk for a negative/
deficit schizophrenia subtype. Alternatively, these re-
sults may reflect increased familiality/heritability of the
negative class, the presence of multiple 1q schizophre-
nia risk genes, or a pleiotropic 1q risk locus or loci, with
stronger genotype-phenotype correlation with negative/
deficit symptoms. Using the second familial latent class,
we identified nominally significant linkage to the origi-
nal 10q peak region.
Conclusion: Genetic analyses of heritable, homoge-
neous phenotypes may improve the power of linkage and
association studies of schizophrenia and thus have rel-
evance to the design and analysis of genome-wide asso-
ciation studies.
Arch Gen Psychiatry. 2009;66(10):1058-1067
S CHIZOPHRENIA (SZ) IS A DE-bilitating psychiatric illnessfor which the pathogenesisremains unclear. Althoughstrongly implicating a num-
ber of genetic regions and promising can-
didate genes, genetic analyses have also
highlighted the causal complexity of the
disorder. Genomic variants and regions
showing association or linkage often dif-
fer between studies, and statistical evi-
dence is frequently unconvincing. Con-
firmed functional variants remain elusive.
The presence of small-effect risk vari-
ants, genetic heterogeneity, incomplete
penetrance, and phenocopies renders the
phenotype immensely challenging for ge-
netic dissection.
Genetic studies of SZ may also be con-
founded by clinical heterogeneity. Schizo-
phrenia has no established biological mark-
ers, and diagnoses are based on the presence
and duration of symptoms, the promi-
nence of which can vary considerably be-
tween patients. Debate has long centered
on whether this phenotypic heterogeneity
reflects causal heterogeneity. Although the
use of operationalized diagnoses has unar-
guably facilitated substantial progress in SZ
research, it also assumes a single causal
model for patients with distinct clinical pro-
files. If this clinical variation reflects the
presence of different causal processes, the
use of more homogeneous clinical pheno-
types may facilitate the identification of
genotype-phenotype correlations.1 Such ap-
proaches have yielded promising findings
in other complex disorders, including at-
tention-deficit/hyperactivity disorder2 and
migraine.3
Some evidence suggests that the ge-
netic cause of SZ may differ between pa-
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tients with distinct clinical profiles. Kendler and col-
leagues4 demonstrated significant clinical differences
between linked and unlinked families for a candidate re-
gion in 8p22-21. Also, in a large association study of the
D-amino acid oxidase activator gene (DAOA) with SZ, sig-
nificant association was detected in a subset of subjects
(n=112) who had experienced major mood episodes but
not in the (much larger) subset (n=597) who had not, and
no association was detected by using the operationalized
SZ diagnosis.5 However, few studies have used a fully data-
driven approach to empirically derive clinical subtypes for
genetic analyses of SZ; to our knowledge, there is just one.
Fanous and colleagues6 recently reported linkage analy-
ses of psychotic subtypes derived by means of latent class
analysis (LCA) of 755 psychotic subjects from 270 Irish
families. They detected 4 regions that showed suggestive
linkage to 1 of the LCA subtypes but little linkage to the
traditional clinical diagnosis.
Interestingly, 1 of the LCA subgroups identified in the
study by Fanous et al resembled “deficit SZ” (DS), a well-
characterized SZ subtype supported by taxometric analy-
sis7 and showing good longitudinal stability.8 Compared
with patients without DS, patients with DS exhibit pri-
mary, enduring negative symptoms9; poorer social func-
tioning; less depression; less suicidal ideation; and fewer
delusions of an exclusively social content while having simi-
lar overall severity of all delusions, hallucinations, and for-
mal thought disorder.10 Family studies suggest utility of the
DS subtype in genetic studies, showing significant corre-
lation for deficit vs nondeficit subtypes in sibling pairs con-
cordant for SZ11 and increased family risk of SZ in indi-
viduals with DS compared with patients without DS.12
However, few studies have reported genetic analyses of DS.
Bakker and colleagues13 reported association of DS with the
PIP5K2Agene on chromosome 10p12, whereas Fanous and
colleagues6 identified suggestive linkage of their deficit class
to a region in chromosome 20.
To further explore the utility of homogeneous subtypes
in identifyingSZrisk loci,weconductedgenome-wide link-
ageanalysesofempiricallyderivedSZsubtypes in1236Tai-
wanese individualswithSZ.14 These individualsweremem-
bersof the largestextantaffected-sibling-pair sample forSZ,
comprising 606 ascertained families. Initial genome-wide
linkage analysis of theDSM-IV SZ diagnosis provided sup-
port for regions in 10q22.3, 2q14.1, 1p31.1, 15q14, and
4q21.23.14 However, no region achieved genome-wide sig-
nificance, with a region in 10q22.3 showing the strongest
evidenceof linkage(z=2.88, logarithmofodds[LOD]=1.8).
We aimed to investigate whether additional regions or in-
creased significance could be detected by means of empiri-
cally derived clinical phenotypes.
METHODS
SAMPLE
This data set was accessed via the National Institute of Mental
Health Center for Collaborative Genetic Studies on Mental Dis-
orders (distribution 5.0) (http://zork.wustl.edu/nimh). The col-
lection of this sample has been previously described.14 Briefly,
affected-sibling-pair families containing at least 2 siblings with
SZ were recruited from 6 centers in Taiwan. Each affected sib-
ling underwent a diagnostic screen using supplemental medi-
cal records and a semistructured interview, followed by the Man-
darin Chinese version of the Diagnostic Interview for Genetic
Studies (DIGS).15,16 The DIGS interview data were supple-
mented with information from medical records and a semi-
structured interview with family members.17,18 Best-estimate fi-
nal diagnoses were assigned by 2 research psychiatrists, with a
third diagnostician resolving any disagreements. The sample
was genotyped by the Center for Inherited Disease Research
for 386 microsatellite markers spaced at 9-cM intervals (aver-
age) genome-wide.
LATENT CLASS ANALYSIS
The number and composition of distinct clinical groups were
empirically determined by means of LCA, a statistical method
for identifying subtypes of related cases from multivariate cat-
egorical data.19 On the basis of clinical experience, we selected
11 symptoms recorded during the DIGS interview that were
deemed to capture the important aspects of clinical variation
(Table 1). The LCA was conducted with Latent Gold soft-
ware (version 4.5; Statistical Innovations Inc, Belmont, Mas-
sachusetts) and included 1236 Han Chinese participants with
aDSM-IV diagnosis of SZ. Latent cluster models specifying from
1 to 10 latent classes were fitted, allowing up to 5000 itera-
tions of the Expectation Maximization algorithm with a con-
vergence criterion of 110−6. To avoid local maxima in pa-
rameter estimation, models were refitted multiple times with
the use of different starting values. The best-fitting model was
selected on the basis of the Bayesian information criterion, as
previously recommended.20 The preferred model was that with
the lowest Bayesian information criterion, providing optimal
balance between fit and parsimony. In addition, we assessed
the clinical interpretability of the identified classes and en-
sured that classes were of nontrivial size. Because many cases
contained missing values for at least 1 indicator variable and
to use all available data, cases containing missing values were
included in the analysis. However, the impact of missing val-
ues was reduced by constructing variables from multiple, re-
lated DIGS items, providing a degree of redundancy. Latent Gold
handles missing indicator values directly in the likelihood func-
tion by basing the likelihood contribution of each case on the
observed indicators only. That is, parameters are estimated by
using all available information for each of the cases.
An important assumption of LCA is that of local indepen-
dence between observed indicator variables. That is, condi-
tional on latent class membership, the indicator variables are
statistically independent (uncorrelated). In cases in which the
local independence assumption does not hold, LCA models may
be modified to provide adequate fit.21 After initial model selec-
tion, we used the Latent Gold software to identify indicator vari-
ables with significant residual association, indicated by a bi-
variate residual (BVR) score greater than 3.84 (equivalent to
P .05 because the BVR statistic is distributed as 21). Residual
association was accounted for by incorporating direct effect para-
meters between significantly correlated variable pairs,22 start-
ing with the highest BVR and proceeding iteratively until all
BVRs were less than 3.84.
FAMILIAL AGGREGATION ANALYSES
Before performing genetic analyses of LCA subtypes, we sought
evidence of a genetic contribution to latent class group member-
ship, which should produce aggregation of group membership
within families. On the basis of all 1236 affected individuals with
SZ, the sample contained 758 possible affected relative pairs
(ARPs). The proportion of ARPs concordant for membership in
(REPRINTED) ARCH GEN PSYCHIATRY/ VOL 66 (NO. 10), OCT 2009 WWW.ARCHGENPSYCHIATRY.COM
1059
©2009 American Medical Association. All rights reserved.
Downloaded From: http://archpsyc.jamanetwork.com/ by a UQ Library User  on 09/13/2015
any latent class was compared with the expected value, which was
derived by means of the marginal probabilities for each latent class.
The expected and observed proportions were treated as bino-
mial variables and compared by means of a normal approxima-
tion. Because the sample contained nonindependent relative pairs
from families containing 3 or more affected individuals, the analy-
sis was repeated with the use of an average of the number of con-
cordant relative pairs within each family, in which each family
was weighted to contribute a single relative pair.
LINKAGE ANALYSIS
On the basis of the posterior probabilities of latent class mem-
bership, affected individuals were assigned to their most likely
latent class. Genome-wide linkage analyses were conducted for
the 2 latent classes exhibiting familial aggregation. For each,
individuals endorsing that class were considered affected and
multipoint exponential LOD scores23 were calculated at 1-cM
increments by means of the Spairs24 sharing statistic imple-
mented in the Merlin program.25 Marker positions were deter-
mined by means of the sex-averaged Marshfield genetic map,26
as for the original analysis. This was considered the primary
linkage analysis.
As a secondary analysis, we also calculated parametric hetero-
geneity LOD (HLOD) scores in the entire, original data set (606
families). Multipoint HLOD scores were calculated under simple
dominant and recessive models, specifying disease allele fre-
quencies of 0.01 and 0.1 and genotype penetrances of (0, 0.5,
0.5) and (0, 0, 0.5) for the dominant and recessive models, re-
spectively, for 0, 1, or 2 copies of the disease allele.27,28
To estimate genome-wide significance levels for our pri-
mary analysis, we used an empiric method.29 For each of the
2 latent class groups used in genetic analyses, Merlin25 was
used to generate 5000 data replicates under the null hypoth-
esis of no linkage, which were analyzed at 1-cM increments by
means of the exponential LOD score.23 We then derived the em-
piric distribution of the maximum LOD score at each position
(LODmax) by recording, for each replicate, the highest LOD
score obtained across the 2 latent class groups. This generated
an empiric distribution of the highest score at each position that
naturally accounts for both multiple testing and the correla-
tion between statistics. The genome-wide significance level as-
sociated with the highest observed score was defined as the fre-
quency of equivalent or higher peaks in the empiric distribution
of LODmax. Linkage peaks separated by more than 40 cM were
considered independent.30,31 Genome-wide significance and sug-
gestive thresholds were defined as scores occurring with a prob-
ability of 0.05 and 1 in every LODmax replicate, respec-
tively,32 and nominal P=.01 and P=.05 thresholds were defined
as scores occurring with a probability of 0.01 and 0.05 at any
map position.
RESULTS
LATENT CLASS ANALYSIS
The LCA included 1236 individuals with SZ (1175 af-
fected siblings and 61 affected parents), with a mean (SD)
age of 36.29 (9.58) years and a mean age at illness onset of
23.05(6.92) years. Males composed 61.5% of the sample.
The affected individuals were contained within 578 fami-
lies, 561 of which contained 2 or more affected sibling pairs
Table 1. Indicator Variables for the Latent Class Analysis and Endorsement Frequencies
Variable (Symptom) Type DIGS Item(s)
Proportion of Subjects
With Symptom
Schneiderian delusions Nominal Control delusions, or having one’s thoughts broadcast, inserted, or withdrawn 0.555
Other delusions Nominal Persecutory, reference, or bizarre (clearly impossible) delusions 0.808
Schneiderian hallucinations Nominal Voices maintaining running commentary, or multiple voices 0.659
Other hallucinations Nominal Somatic, tactile, olfactory, visual, or gustatory hallucinations 0.610
Disorganization Nominal Bizarre behavior or disorganized speech 0.616
Global symptom severity Ordinal Global assessment of symptoms (past month); score 1-100 reflecting level of
social and occupational function
Severe functional impairment; score 40 0.399
Moderate functional impairment; score 41-61 0.460
Mild or no impairment; score 61 0.141
Pattern of symptoms Nominal 4 classes representing common longitudinal profiles of positive and negative
symptoms
Continuously positive 0.294
Predominantly negative 0.142
Positive converting to negative 0.163
Mixture of positive and negative 0.371
Age at illness onset Ordinal Early (20 y) 0.373
Intermediate (20-35 y) 0.564
Late (35 y) 0.063
Suicide attempt(s) Nominal History of 1 suicide attempt 0.275
Affective flattening Ordinal Global rating of affective flattening (reduced emotional expression)
No symptoms 0.316
Mild symptoms 0.335
Moderate to severe symptoms 0.334
Alogia (poverty of speech) Ordinal Global rating of alogia (poverty of speech)
No symptoms 0.316
Mild symptoms 0.331
Moderate to severe symptoms 0.334
Abbreviation: DIGS, Diagnostic Interview for Genetic Studies.
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(28 of the original 606 families had no diagnostic and/or
symptom data available and 17 had data for 1 sibling only).
Of the 561 multiple-sibling families, 524 families con-
tained 2 affected siblings, 36 contained 3 affected siblings,
and 1 family contained 4 affected siblings. Genotype data
were available for all individuals included in the LCA.
After fitting a single-class solution, a continuous im-
provement in fit was observed up to a 4-class solution; the
relevant Bayesian information criterion values were
20463.27 (1 class), 19527.27 (2 classes), 19425.43 (3
classes), 19370.09 (4 classes), and 19401.08 (5 classes).
To evaluate the robustness of our LCA model, we re-
peated the primary Latent Gold analysis by using the LCA
procedure of SAS. Identical results were obtained, show-
ing that our model was not sensitive to the particular soft-
ware package used. We also repeated the Latent Gold analy-
sis 20 times, each time randomly selecting 90% of the
original sample for inclusion. Each run identified the same
4-class solution, with individuals being classified into the
same latent class with 96.8% consistency across the 20 runs.
Assessment of Latent Gold’s BVR output for the 4-class
solution showed several BVRs greater than 3.84, sug-
gesting a number of pairwise correlations between indi-
cator variables remaining unexplained by the model. To
ensure conditional independence of the LCA solution,
we used the Latent Gold software to iteratively incorpo-
rate direct effects between all variable pairs with a BVR
greater than 3.84. The results of the final, 4-class solu-
tion are shown in Table 2 and Figure 1.
Visual comparison of the 4 cluster profiles suggests
qualitative differences between the identified pheno-
typic subgroups. A profile analysis of variance statisti-
cally validated these differences, rejecting the hypoth-
esis of parallelism of the 4 plots (F57,1628=85.52, P .001).
This suggests an underlying phenotypic structure of 4
distinct categories rather than a single continuum of li-
ability, which would produce classes differing primarily
in symptom severity.33 The 4 classes were most differ-
entiated by the levels of disorganization, functional im-
pairment, negative symptoms (alogia and affective flat-
tening), and overall symptom pattern. Negative symptoms
best differentiated the 4 groups, with endorsement prob-
abilities differing by approximately 90% between the least
and most severely affected groups. All 4 classes exhib-
ited high levels of delusions and hallucinations.
The largest subgroup, LC1 (=0.43, n=533) was not
distinguished by marked presence or absence of any par-
ticular symptom, rather demonstrating moderate levels
of delusions, hallucinations, disorganization, func-
tional impairment, suicidality, and negative symptoms.
The pattern of symptoms for this class was most likely
to be a mixture of positive and negative symptoms.
The other 3 subgroups were more symptomatically dis-
tinctive. The second largest class, LC2 (=0.29, n=370)
described a subtype characterized by moderate to se-
vere negative symptoms (flat affect and alogia), promi-
nent disorganization (speech and behavior), and marked
to severe functional impairment. This class described a
Table 2. Class Membership and Symptom Endorsement Probabilities for the 4-Cluster Latent Class (LC) Solution
LC1 LC2 LC3 LC4
 Estimatesa 0.4246 0.2897 0.1630 0.1227
 Estimatesb
Schneiderian delusions present 0.5004 0.4999 0.6602 0.7831
Other delusions present 0.8292 0.7629 0.7882 0.8553
Schneiderian hallucinations present 0.6445 0.5696 0.7470 0.7470
Other hallucinations present 0.6108 0.5977 0.6254 0.6195
Disorganized speech/behavior present 0.5766 0.8238 0.4695 0.4698
Global symptom severity
Major functional impairment 0.3251 0.6532 0.0268 0.5471
Moderate to serious symptoms 0.5775 0.3314 0.4133 0.4225
Mild or no symptoms 0.0975 0.0154 0.5599 0.0303
Pattern of symptoms
Continuously positive 0.2442 0.0446 0.5860 0.7480
Predominantly negative 0.1128 0.2585 0.1129 0.0418
Positive converting to negative 0.1832 0.2203 0.0829 0.1014
Mixture of positive and negative 0.4599 0.4766 0.2181 0.1088
Age at onset, y
20 0.3571 0.3973 0.4165 0.3126
20-35 0.5748 0.5485 0.5340 0.6028
35 0.0681 0.0542 0.0495 0.0847
Suicide attempt(s) present 0.2824 0.1993 0.3184 0.3692
Affective flattening
None 0.1885 0.0029 0.9062 0.7378
Mild 0.5927 0.1454 0.0928 0.2531
Moderate to severe 0.2189 0.8517 0.0010 0.0091
Alogia (poverty of speech)
None 0.2215 0.0007 0.9345 0.5930
Mild 0.6006 0.0791 0.0651 0.3855
Moderate to severe 0.1779 0.9202 0.0004 0.0215
aClass membership probabilities.
b Item response probabilities, conditional on latent class membership.
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category of severely affected patients with SZ resem-
bling DS. Of the 4 classes, individuals in LC2 were the
least likely to experience delusions and hallucinations,
although these symptoms were still present in a major-
ity of individuals. Individuals in LC2 were also the least
likely to have attempted suicide.
Of the 4 classes, subjects in LC3 (=0.16, n=213) were
the least severely affected, demonstrating the highest level
of global functioning, a virtual absence of negative symp-
toms, and the lowest levels of disorganization. This group
had a pattern of symptoms characterized by predomi-
nantly positive symptoms when ill, but relatively few
symptoms during remissions.
The fourth and smallest class (LC4; =0.12, n=120)
displayed prominent delusions and hallucinations, mod-
erate disorganization, and moderate to marked func-
tional impairment. Individuals in this class were most
likely to experience continuous, positive symptoms and
were also the most likely to have attempted suicide. Nega-
tive symptoms were absent or mild for almost all indi-
viduals in this group.
FAMILIAL AGGREGATION ANALYSES
To justify linkage analysis of the identified latent classes,
it was important to demonstrate familial aggregation of
class membership, indicative of an underlying genetic in-
fluence. On the basis of the marginal probabilities of LC1,
LC2, LC3, and LC4 (0.43, 0.29, 0.16, and 0.12, respec-
tively), the expected number (proportion) of total con-
cordant ARPs was 232 (0.31). The observed number (pro-
portion) was 257 (0.339) (z=1.97, P=.02), suggesting
marginally significant overall familial aggregation. How-
ever, this aggregation was nonsignificant when each fam-
ily was weighted to contribute a single relative pair
(z=1.38, P=.08). Among individual classes, a signifi-
cant excess of concordant relative pairs was observed for
only 2 classes, LC2 and LC3. For these classes, ARP class
concordance was elevated on the basis of counts of both
total relative pairs (LC2: z=2.27, 1-sidedP=.01; LC3: z=2,
P=.02) and independent pairs per family (counted asR−1,
where R is the number of affected individuals in the fam-
ily) (LC2: z= 3.26, 1-sided P .001; LC3: z= 2.58,
P=.005). The excess was nonsignificant for LC1, and LC4
had fewer observed than expected concordant relative
pairs. This supports a role of familial factors in the eti-
ology of LC2 and LC3.
LINKAGE ANALYSES
Incorporating correction for testing both LC2 and LC3,
empiric genome-wide significant and suggestive linkage
thresholds of 3.14 and 1.86 and nominal P=.01 and P=.05
thresholds of 1.45 and 0.84 were determined. Linkage
analyses of LC2 included 257 individuals contained within
64 families, incorporating 67 total or 66 independent sib-
ling pairs. Analyses of LC3 included 93 individuals con-
tained within 23 families, with 25 total and 24 indepen-
dent sibling pairs. Genome-wide multipoint LOD scores23
for the LC2 and LC3 subsets are shown in Figure 2.
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Figure 1. Profile plot for latent classes (LCs) under the 4-class model. Item response probabilities indicate the proportion of individuals in each class exhibiting
each symptom. Symptom descriptions are provided in Table 1.
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For LC2, the strongest linkage evidence was ob-
served at 1q23-25, 189 cM from the p-telomere
(LOD=3.78). This result easily surpassed the threshold
for genome-wide significant linkage, with only 61 peaks
of 3.78 or greater occurring in 5000 simulations of
LODmax (genome-wide P=.01, incorporating correc-
tion for testing both LC2 and LC3). The 1-LOD drop
(approximating a 95% confidence interval for the loca-
tion of the peak) delimited a 15-cM region from 183 to
198 cM (approximately 166.6-180.6 megabases, Na-
tional Center for Biotechnology Information Build 36.2).
To explore the potential mode of inheritance of the pu-
tative chromosome 1 locus, we calculated multipoint
HLOD scores under simple dominant and recessive mod-
els (see the “Methods” section for model parameters).
These exploratory analyses demonstrated greater link-
age evidence under a recessive (peak HLOD=3.539) rather
than a dominant (peak HLOD=2.403) model.
Single-point LOD scores greater than 1 were ob-
served for 4 markers in the 1q region: D1S1679
(LOD = 1.07), D1S1619 (LOD = 2.72), D1S1589
(LOD=1.41), and D1S518 (LOD=1.38), supporting the
multipoint results. In the LC2 subset, an additional 2 re-
gions achieved nominal P .01 and a total of 6 regions
achieved nominal P .05 (Table 3).
For LC3, no region achieved genome-wide significant
linkage, suggestive linkage, or nominal P .01. Ten re-
gions achieved nominalP.05 (Table 3). One of these was
located on 10q22.1 (peak LOD=1.19, 94 cM from p-ter)
andoverlapped themaximumlinkagepeakdetected inorigi-
nal analyses of these data using the DSM-IV SZ diagnosis
(peak LOD=1.8, z=2.88, 100.9 cM from p-ter).
Parametric analyses of the original (entire) data set de-
tected the strongest linkage evidence on 10q22.1 (HLOD-
dominant=2.402), in the same region as the original peak
z score. Nine other peaks achieved HLOD scores greater
than 1 under either the dominant or recessive model
(Table 4). The 1q region detected with the use of LC2
showed little linkage evidence in the entire sample (peak
HLOD=0.738; recessive model, 216 cM from p-ter).
COMMENT
This is the second linkage study of SZ to use categorical
phenotypes empirically derived from observed symp-
tom profiles. We proposed that, if clinical heterogeneity
reflects genetic heterogeneity, homogeneous clinical sub-
types may allow the identification of genomic regions that
the traditional diagnosis did not.
Our LCA identified a familial SZ subtype with
prominent negative symptoms. The characteristics of
this class showed striking similarity to a subtype also
described by Fanous et al.6 In addition to prominent
negative symptoms, individuals in both classes demon-
strated high levels of social dysfunction and lower-
than-average probabilities of delusions, hallucinations,
and Schneiderian psychotic symptoms. Although we
did not include depressive and manic items in our LCA,
independent assessment of their probabilities in our
negative subtype (data not shown) showed values lower
than the sample median, consistent with Fanous et al.6
Individuals in our negative subtype also demonstrated
prominent disorganization and low suicidality; how-
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Figure 2. Results of genome-wide nonparametric linkage analysis of the 2 latent classes (LCs) demonstrating familial aggregation. Empiric thresholds for
genome-wide significant linkage, genome-wide suggestive linkage, nominal P=.01, and nominal P=.05 are shown. LOD indicates logarithm of odds.
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ever, these symptoms were not included in the Fanous
et al study.
This negative subtype resembles DS. However, an im-
portant characteristic of DS is the presence of primary
negative symptoms as opposed to those arising second-
ary to factors such as depression, paranoia, or preoccu-
pation with psychotic symptoms.34 The available data did
not allow us to distinguish between primary and second-
ary negative symptoms in our deficit (LC2) subset. Al-
though LC2 demonstrated several features consistent with
DS—including lower levels of depression,35 suicidality,
and social/occupational function36 in the presence of simi-
lar (lower) overall levels of delusions and hallucina-
tions—it also showed high levels of disorganization (in-
corporating formal thought disorder), which may
influence the severity of negative symptoms. Thus, de-
spite these similarities, our limitation in addressing the
primary/secondary distinction precludes us from describ-
ing our LC2 subset as classic DS.
Linkage analyses of our negative subtype (LC2) iden-
tified a region of genome-wide significant linkage in 1q23-
25. Both the original analysis and our secondary para-
metric heterogeneity analyses failed to detect linkage to
this region, despite the latter’s putative allowance for lo-
cus heterogeneity. This region has previously shown
highly significant linkage to SZ in a Canadian sample37,38
and has also shown linkage to SZ in 2 Chinese stud-
ies39,40 and a European study.41 Furthermore, this re-
gion has been implicated in SZ susceptibility in 2 ge-
nome scan meta-analyses of SZ.42,43 Our results may
suggest that variants in 1q23-25 specifically increase the
risk for a negative/deficit subtype of SZ. In this case, al-
though our LC2 subset was modest in size (64 families),
its high phenotypic homogeneity may have increased the
proportion of 1q-linked families and power to detect link-
age. Alternatively, our detection of the 1q region may have
resulted less from the specific phenotypic features of the
LC2 subset than our use of a familial/heritable SZ sub-
type. Indeed, Fanous et al6 did not identify linkage of their
deficit subtype to this 1q region, but rather detected link-
age to a region in chromosome 20. However, these dif-
ferences may reflect the presence of further genetic hetero-
geneity within negative/deficit subtypes or statistical
variation relating to power, given the modest number of
deficit sibling pairs included in our study (67 pairs) and
the Fanous study (32 pairs).
Table 3. Linkage Regions Achieving Nominal P .05 for the 2 Familial LCs
Chromosome Class Map Position, cM Multipoint LOD Nearest Marker Marker Position, cM
1 LC2 189 3.78a D1S1619 188.32
7 LC2 121 1.53 D7S3061 128.41
9 LC2 119 1.20 D9S930 120.04
10 LC2 159 1.68 D10S217 157.89
12 LC2 152 1.37 D12S2078 149.60
15 LC2 58 1.34 D15S1507 60.17
1 LC3 126 0.86 D1S1588 125.51
1 LC3 215 1.22 D1S1647 215.99
3 LC3 87 1.06 D3S4542 89.91
4 LC3 79 0.97 D4S2367 78.43
7 LC3 92 0.98 D7S2204 90.95
10 LC3 94 1.19 D10S1432 93.92
11 LC3 119 0.94 D11S4464 123.00
12 LC3 83-85 0.87 D12S1052 83.19
12 LC3 145 1.37 D12S2078 149.60
14 LC3 12 0.95 D14S742 12.46
Abbreviations: LCs, latent classes; LOD, logarithm of odds.
aSatisfies criteria for genome-wide significant linkage, incorporating correction for testing both LC2 and LC3.
Table 4. Regions Showing Evidence of Linkage in Entire Data Set Using Parametric Heterogeneity Logarithm of Odds (HLOD) Scoresa
Chromosome Map Position, cM HLOD Nearest Marker Marker Position, cM Model With Strongest Evidenceb
1 226 1.150 C1S1248 226.16 Dominant
2 129 1.854 D2S410 125.18 Recessive
4 94 1.418 D4S2361 93.48 Dominant
5 163 1.039 D5S820 159.77 Dominant
10 103 2.402 D10S2327 100.92 Dominant
10 144 1.815 D10S1230 142.78 Dominant
11 119 1.165 D11S4464 123.00 Dominant
12 72 1.093 D12S398 68.16 Dominant
15 85 1.248 D15S655 82.84 Recessive
19 75 1.298 D19S246 78.08 Dominant
aRegions achieving HLOD greater than 1 are shown.
bDominant and recessive models specified disease allele frequencies of 0.01 and 0.1 and genotype penetrances of (0, 0.5, 0.5) and (0, 0, 0.5), respectively.
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Involvement of the 1q23-25 region in a negative/
deficit SZ subtype may also be specific to the Han Chi-
nese population or have resulted from this sample’s as-
certainment characteristics. A striking feature of this
Taiwanese sample was a low rate of comorbid substance
use/abuse, with just 5.2% and 3.7% of affected siblings
reporting alcohol or drug abuse/dependence, respec-
tively.44 In our negative class, the equivalent rates were
3.1% and 0.8%, which may have further increased phe-
notypic homogeneity and power to resolve SZ risk loci.
Further research is required to clarify the structure, heri-
tability, and relevant risk loci for negative/deficit sub-
types of SZ and to determine the generalizability of our
findings to other samples and populations.
Several genes in the 1q region have shown statistical as-
sociation with SZ, although none of the evidence is com-
pelling. Perhaps the best studied is the regulator of G-
protein signaling 4 gene (RGS4), which is located in 1q23.3
and has shown modest association in multiple studies45-50
and one meta-analysis,51 although negative results have also
been reported.52-54 Intriguingly, one recent study reported
association of an RGS4 single-nucleotide polymorphism
with severity of negative symptoms and neurocognitive per-
formance,55 although another study reported negative as-
sociation of DS with RGS4 single-nucleotide polymor-
phisms.13 Other genes in the 1q region showing some level
of association with SZ include CAPON,56,57 CHRNB2,58
Cx50,59 and UHMK1.60,61 Interestingly, 2 recent, promi-
nent studies detected association of SZ to a large, recur-
rent microdeletion in 1q21.1.62,63 However, the deletion is
rare (frequency, 1% in cases) and thus likely accounts
for little linkage to the 1q region. Other studies have shown
association of SZ with a heterochromatin variant64 and a
fragile site65 in 1q21. Comprehensive research in larger data
sets—including genotype-phenotype analyses—may help
to identify genetic variants in the 1q region involved in SZ
susceptibility.
The other class demonstrating familiality in this study
(LC3) described the least severely affected subgroup, dem-
onstrating high global functioning, low disorganiza-
tion, and a virtual absence of negative symptoms. Link-
age analyses of LC3 detected evidence of linkage (nominal
P .05) to a region in 10q overlapping the primary link-
age peak detected in original analyses of these data.14 How-
ever, any phenotypic interpretation of these results should
be undertaken cautiously because of the modest num-
ber of concordant sibling pairs included in the linkage
analysis of LC3 (25 total pairs).
Our results should be interpreted in light of several
considerations. First, the latent class typology we report
is dependent on the response variables we selected for
the LCA and the statistical method we used for selecting
the best-fitting model. It remains to be shown whether
these results differ with the use of different response vari-
ables, other rating instruments, or different diagnostic
systems. The inclusion of additional symptoms may also
result in the identification of further latent classes. Sec-
ond, although the familial aggregation of LC2 and LC3
group membership suggests genetic influences, it could
also reflect shared environmental effects. Twin studies
could help to clarify the respective contributions of ge-
netic and environmental effects to subtype liability. Third,
the size and position of our linkage peaks may have been
influenced by the number of sibling pairs concordant for
each LCA subtype, with the number of total concordant
sibling pairs for LC2 and LC3 being 67 and 25, respec-
tively. It is possible that the detection of significant link-
age with LC2, but not LC3, reflected power differences
relating to sample size. However, the position of the 10q
peak accords well with those reported in other studies,
supporting the validity of its location.
In conclusion, our results suggest that the identifica-
tion and analysis of homogeneous, heritable clinical sub-
types may be an important avenue to progress in SZ ge-
netics research. Reduced genetic heterogeneity in such
subtypes may increase power to identify particular risk
variants. Although genetic studies have achieved sub-
stantial progress by means of the traditional SZ diagno-
sis, exclusive reliance on DSM-IV diagnostic categories
of SZ, albeit in ever-increasing samples, may not be suf-
ficient for dissecting its genetic complexity. If the clini-
cal SZ diagnosis comprises multiple, causally divergent
subtypes or dimensions, additional value may be ex-
tracted from existing and future data sets by conducting
empiric analyses of comprehensive phenotype data to
identify homogeneous clinical subtypes and dimen-
sions. The analysis of such alternative phenotypes may
be an important, complementary approach for clarify-
ing the genetic cause of SZ.
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